Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Business
Corp. News
Latest Headlines
Biotech
Investors
Stock Alerts
IPOs
M&A
Top Stories
Breaking News
Earnings
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Crypto
Cryptocurrency
Blockchain
Markets
Market News
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
US
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health News
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment News
Top Stories
Music News
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium
Intelligent Investor
Biotech Investor
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Telix Pharmaceuticals Limited (TLX.AX)
Telix Pharma Doses First Patient In Phase 3 IPAX BrIGHT Trial Of TLX101-Tx; Prices $600 Mln Bonds
4/15/2026 5:27:13 AM
Regeneron Pharma Partners Telix Pharma To Jointly Develop Radiopharmaceutical Therapies
4/13/2026 6:54:45 AM
Telix Partners With Regeneron To Develop Radiopharmaceutical Therapies
4/13/2026 6:37:28 AM
Telix And Regeneron Partner To Advance Next-Generation Radiopharmaceutical Therapies
4/12/2026 11:28:52 PM
Telix Pharmaceuticals Stock Gains 7% On FDA Acceptance Of Resubmitted NDA For TLX101-Px
4/10/2026 11:03:14 AM
Telix Pharma Shares Climb As FDA Accepts NDA For Brain Cancer Imaging Agent TLX101-Px
4/10/2026 1:04:36 AM
Telix Pharmaceuticals' Resubmitted NDA For Brain Cancer Imaging Agent TLX101-Px1 Accepted By FDA
4/9/2026 9:13:49 PM
Telix Pharmaceuticals Stock Rises 5% Over Strong Revenue Growth In Q1
4/7/2026 11:05:04 AM
Telix Pharma Reports 24% Revenue Growth In Q1; Stock Up
4/7/2026 2:45:16 AM
Telix Pharmaceuticals Q1 Group Revenue Rises; Stock Up
4/6/2026 10:35:31 PM
Weekly Buzz: GSK's Lynavoy Gets FDA Nod; Reproxalap Rejected Again; LNSR Ends Merger Deal
3/20/2026 10:13:56 AM
Telix Resubmits NDA For Brain Cancer Imaging Candidate TLX101-Px To FDA
3/16/2026 5:41:20 AM
Telix Resubmits TLX101-Px NDA To FDA For Brain Cancer Imaging Agent
3/15/2026 8:59:50 PM
Telix Pharmaceuticals Shares Rise 14% On Revenue Growth, 2026 Outlook
2/20/2026 11:00:54 AM
Telix Pharma FY25 Adj. EBITDA Declines; Revenue Up 56%
2/20/2026 12:55:47 AM
Telix Pharma Forecasts FY26 Revenue Of US$950M-US$970M
2/19/2026 9:05:11 PM
Telix Pharma FY'25 Revenue Jumps 56% To US$803.8 Mln
2/19/2026 9:01:34 PM
Telix Pharmaceuticals FY Operating Profit Drops To US$29.8 Mln From US$55.2 Mln Prior Year
2/19/2026 7:37:23 PM
Telix Submits European Marketing Authorization Application For TLX101-Px
2/18/2026 1:10:55 AM
Telix Files European Marketing Authorization Application For TLX101-Px In Brain Cancer Imaging
2/17/2026 7:51:46 PM
Older Articles